{"cdcTestId":"2013-0607","testcaseName":"Dose # 1 PCV 13 at age 6 weeks-4 days","vaccineGroup":"PCV","evaluationTestType":"Age: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-09-11T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-20T00:00:00","recommendedDate":"2023-01-11T00:00:00","pastDueDate":"2023-03-10T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-29T07:39:53.087","generalDescription":"This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at 6 weeks - 4 days that the dose is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}